| 1 |
32975132 | Designing orodispersible films containing everolimus for enhanced compliance and bioavailability. | 2020 Oct |
1 |
| 2 |
29547545 | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients. | 2018 Mar 16 |
1 |
| 3 |
29727013 | Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures. | 2018 Jun |
1 |
| 4 |
29992479 | Population pharmacokinetics-pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex. | 2018 Oct |
1 |
| 5 |
28727815 | Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer. | 2017 |
3 |
| 6 |
27399255 | Drug interaction between dabrafenib and immunosuppressive drugs: about one case. | 2016 Oct |
1 |
| 7 |
24332451 | Relationship between everolimus exposure and safety and efficacy: meta-analysis of clinical trials in oncology. | 2014 Feb |
2 |
| 8 |
24522145 | Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation. | 2014 Feb 12 |
1 |
| 9 |
23426978 | A phase I study evaluating the effect of everolimus on the pharmacokinetics of midazolam in healthy subjects. | 2013 Apr |
3 |
| 10 |
22006179 | A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. | 2012 May 1 |
1 |
| 11 |
21177421 | Everolimus: a new mammalian target of rapamycin inhibitor for the treatment of advanced renal cell carcinoma. | 2011 Jan |
1 |
| 12 |
21389905 | CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients. | 2011 Mar 27 |
2 |
| 13 |
22016125 | [Drug interactions and immunosuppression in organ transplant recipients]. | 2011 Oct 18 |
1 |
| 14 |
20137762 | Sotrastaurin and everolimus pharmacokinetics after single-dose coadministration. | 2010 Feb |
1 |
| 15 |
19499965 | Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient. | 2009 |
2 |
| 16 |
19728747 | Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. | 2009 |
1 |
| 17 |
18223473 | Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor. | 2008 Feb |
1 |
| 18 |
18812562 | Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient. | 2008 Nov |
1 |
| 19 |
16955532 | Everolimus drug interactions: application of a classification system for clinical decision making. | 2006 Dec |
3 |
| 20 |
15831774 | Blood concentrations of everolimus are markedly increased by ketoconazole. | 2005 May |
1 |
| 21 |
16187976 | Pharmacokinetic interaction between verapamil and everolimus in healthy subjects. | 2005 Oct |
1 |
| 22 |
14748618 | Clinical pharmacokinetics of everolimus. | 2004 |
1 |
| 23 |
15041395 | The evolving experience using everolimus in clinical transplantation. | 2004 Mar |
1 |
| 24 |
12022896 | Effect of rifampin on apparent clearance of everolimus. | 2002 Jun |
1 |
| 25 |
12457444 | Review of the proliferation inhibitor everolimus. | 2002 Dec |
1 |
| 26 |
11557912 | Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications. | 2001 Sep |
1 |